SFX by Ex Libris Inc.

Title:	Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
Source:	Nature [0028-0836] Huang, J yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Bacterial Endophytes: A Reservoir of Bioactive Anti-Microbial Compounds." Life sciences, medicine and biomedicine 2.1.
description	2.	Mao, Y. "Subunit organization of the membrane-bound HIV-1 envelope glycoprotein trimer.(Report)." Nature Structural & Molecular Biology 19.9 (2012): 893-.
description	3.	June, Carl H. "T cell engineering as therapy for cancer and HIV: our synthetic future." Philosophical transactions - Royal Society. Biological sciences 370.1680 (2015): 20140374-10.
description	4.	Kwong, K. "Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization." Science 340.6133 (2013): 751-756.
description	5.	Bournazos, S. "HIV therapy by a combination of broadly neutralizing antibodies in humanized mice." Nature advance online publication.7427 (2012): 118-122.
description	6.	Barrett, David M. "Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street." The journal of immunology 195.3 (2015): 755-61.
description	7.	Freed, Eric O. O. "HIV-1 assembly, release and maturation." Nature Reviews Microbiology 13.8 (2015): 484-496.
description	8.	Sharpe, M. "Genetically modified T cells in cancer therapy: opportunities and challenges." Disease models & mechanisms 8.4 (2015): 337-350.
description	9.	Derking, R. "Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer." PLOS pathogens 11.3 (2015).
description	10.	Cohen, J. "More Woes for Struggling HIV Vaccine Field." Science 340.6133 (2013): 667-667.
description	11.	Zolla Pazner, S. "Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial." PLoS ONE 8.1 (2013).
description	12.	MothÃ, Bianca R. "Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles." Immunogenetics 65.5 (2013): 371-386.
description	13.	Fahnestock, S R R. "Evidence of the involvement of a 50S ribosomal protein in several active sites." Biochemistry 9999.9999 (1975): 5321-7.
description	14.	Wu, X. "Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1." Science 329.5993 (2010): 856-861.
description	15.	Yeeles, J. "The processing of double-stranded DNA breaks for recombinational repair by helicase-nuclease complexes." DNA repair 9.3 (2010): 276-85.
description	16.	Neitz, M. "Gene therapy for red-green colour blindness in adult primates." Nature 461.7265 (2009): 784-787.
description	17.	Rathaur, S. "Filarial glutathione-S-transferase: A potential vaccine candidate against lymphatic filariasis." Vaccine 26.32 (2008): 4094-4100.
description	18.	Poignard, P. "Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation." The Journal of experimental medicine 183.2 (1996): 473-84.
description	19.	John C. Fletcher, C. "Moral Problems and Ethical Issues in Prospective Human Gene Therapy." Virginia law review 69.3 (1983): 515-546.
description	20.	Poignard, P. "Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo." Immunity 10.4 (1999): 431-8.